TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Medibank Private ( (AU:MPL) ) has issued an update.
Medibank Private Limited has announced the appointment of Jacqueline Hey and Dr. Lisa McIntyre as non-executive directors, effective from November 19, 2025. This strategic addition to the board is expected to enhance the company’s governance and potentially strengthen its market position, reflecting Medibank’s commitment to robust leadership and strategic oversight.
The most recent analyst rating on (AU:MPL) stock is a Buy with a A$5.84 price target. To see the full list of analyst forecasts on Medibank Private stock, see the AU:MPL Stock Forecast page.
More about Medibank Private
Medibank Private Limited is a prominent player in the health insurance industry, offering a range of health insurance products and services. The company focuses on providing comprehensive health coverage and related services to its customers, positioning itself as a leader in the Australian health insurance market.
Average Trading Volume: 5,882,641
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$13.38B
See more data about MPL stock on TipRanks’ Stock Analysis page.